Alternatives to Quiver Bioscience

A biotechnology company developing genetic therapies for rare disorders.

Venture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Scalable, one-time curative in-vivo gene editing therapies.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Enzyme-based technology to break down alcohol in the stomach.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.